Champions Oncology, Inc. (CSBR)
NASDAQ·Healthcare·Biotechnology
$5.90
—
Mkt Cap $81.23M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$12.00
Range $12.00 – $12.00
Implied Upside
+103.4%
Consensus $12.00 vs current $5.90
NASDAQ·Healthcare·Biotechnology
$5.90
—
Mkt Cap $81.23M
No recent rating data.
Price Target (1 analysts)
$12.00
Range $12.00 – $12.00
+103.4%
Consensus $12.00 vs current $5.90